EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
Clinical trial NCT00821717 · TERMINATED
Trial details
- NCT number
- NCT00821717
- Sponsor
- Vifor Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.